What Google Ads Healthcare Policy Actually Says About Selling Peptides Online: The Exact Lines (2026)

This guide reproduces 42 lines from one Google Ads policy page, retrieved on 2026-10-08, sorted by policy section. None of the 136 captured policy entries mentions peptides, and Meta's drugs and pharmaceuticals standard could not be read on 2026-10-08 (PAY-012). This article reports the policy's own words and does not say what Google would do with any peptide ad.

Updated October 28, 2026.

What is the source behind these lines?

Google's healthcare and medicines policy page is where the Google lines in this guide were captured, on 2026-10-08 (PAY-200). The page states that some types of healthcare-related content can't be advertised at all, while others can only be advertised in certain locations by advertisers who have applied and been approved (PAY-233). In plainer words, the page separates content that can't be advertised from content that needs an application and approval (PAY-233). The page also states that the English version is the official language used to enforce Google Ads policies (PAY-236). If you rely on a translation, check the English wording quoted in the tables below.

Does the captured policy say anything about peptides?

The captured Google Ads policy lines do not mention peptides, so no line below can be read as a statement about them. Google restricts "the use of prescription drug terms in ads, landing pages, and keywords" (PAY-500), and under unauthorized pharmacies it states "Offering prescription drugs without a prescription is not allowed" (PAY-502). In plainer words, these lines speak of prescription drug terms and pharmacies, not of a named compound class (PAY-500, PAY-502). The captured sources do not say whether any peptide product falls under these lines. Read each section's quoted lines in the tables below before deciding whether any of them bears on your pages.

Lookup table: the general rules of the healthcare policy

Google's healthcare policy page expects ads and destinations to follow appropriate laws and industry standards (PAY-232). It also states that you're expected to familiarize yourself with the local law and regulations for any location your ads target (PAY-235). In plainer words, the page asks advertisers to follow appropriate laws and industry standards and to learn the local law for each place they target (PAY-232, PAY-235). Compare your own ads and destination pages with these expectations.

What does the Unapproved substances section list?

Google's Unapproved substances section states "Google doesn't allow the promotion of certain products, regardless of any claims of legality: All items on this non-exhaustive list of unapproved pharmaceuticals and supplements" (PAY-009). The table below quotes lines from the section, including "Products that contain ephedra" (PAY-200) and "Dehydroepiandrosterone (DHEA) except in campaigns targeting the United States" (PAY-207). In plainer words, the DHEA line carries an exception for campaigns targeting the United States (PAY-207). The captured sources do not say that these lines are the full list. Compare the ingredients in your own products against these lines.

Which Unapproved substances lines mention effectiveness claims?

Google's Unapproved substances section lists "Non-government approved products that are marketed in a way that implies that they're safe or effective for use in preventing, curing, or treating a particular disease or ailment" (source: Google Ads healthcare and medicines policy) (PAY-010). It also lists "Products that imply they're as effective as prescription drugs or controlled substances" (PAY-203). In plainer words, these lines concern what a product implies, and the line on non-government approved products ties that to how the product is marketed (PAY-010, PAY-203). This guide does not assess any seller's wording against either line. Compare your own product pages against these lines.

What does the regulatory action or warning line say?

Google's Unapproved substances section lists products that have been subject to any government or regulatory action or warning among the products it doesn't allow the promotion of (PAY-205). In plainer words, the line covers "any government or regulatory action or warning" taken or given about a product (PAY-205). The captured page does not define which actions or warnings count, and the sources captured for this guide do not say how Google applies the line to any specific product. Compare any government or regulatory correspondence about your products against this line.

Google doesn't allow the promotion of products with names that are confusingly similar to an unapproved pharmaceutical or supplement or controlled substance (PAY-206). The line is part of the Unapproved substances section, under the sentence "Google doesn't allow the promotion of certain products, regardless of any claims of legality" (PAY-206). In plainer words, the line concerns product names that are confusingly similar to the kinds of product it names (PAY-206). Compare your product names with that wording.

What does Google restrict about prescription drug services and terms?

Google restricts the promotion of services related to the online prescribing, dispensing, and sale of prescription drugs (PAY-011). It states that businesses subject to the policy include but aren't limited to online pharmacies and telemedicine providers (PAY-208), and that advertisers must apply to serve ads for prescription drug services (PAY-209). In plainer words, the businesses covered include online pharmacies and telemedicine providers and are not limited to them (PAY-208). Check whether your own business is described by these lines.

Google restricts the use of prescription drug terms in ads, landing pages, and keywords (PAY-500). In plainer words, the restriction reaches the wording of ads, of landing pages and of keywords (PAY-500). The page adds that, depending on location, you may be able to use these terms for the purpose of promoting prescription drugs (PAY-211). Compare the wording on your own ads, landing pages and keywords with this restriction.

"Doesn't allow" versus "restricts" in the captured policy

What are the Unauthorized pharmacies lines, and what is the enforcement language?

Google's Unauthorized pharmacies section states that offering prescription drugs without a prescription is not allowed (PAY-502). It also says violations of the policy are taken very seriously and are considered egregious (PAY-214). The page defines an egregious violation as one so serious that it is unlawful or poses significant harm to users (PAY-215). In plainer words, the page calls such a violation egregious when it is unlawful or poses significant harm to users (PAY-215). Read the section's quoted lines in the table below before drafting any pharmacy-related copy.

Google's Unauthorized pharmacies section says accounts are only reinstated in compelling circumstances, and when there is good reason (PAY-217). It also says that if you believe there's been an error, and that you haven't violated the policy, you can submit an appeal and explain why (PAY-503). In plainer words, reinstatement is limited to the circumstances the page names, and an advertiser who believes it did not violate the policy can appeal (PAY-217, PAY-503). Read the page's other sections directly to see what applies to your pages.

Unauthorized pharmacies: what the policy says follows a violation

Which certifications does the online pharmacies line name?

Google allows online pharmacies "if they're accredited by one of the organizations listed below", including LegitScript's Healthcare Merchant Certification Program Internet pharmacy certification (PAY-237), NABP Digital Pharmacy Accreditation (PAY-238), and .Pharmacy as part of the Healthcare Merchant Accreditation Program (PAY-239). It allows telemedicine providers if they're accredited by LegitScript's Healthcare Merchant Certification Program (PAY-240). It adds that "Advertisers must also be certified with Google" (PAY-241). In plainer words, accreditation is the stated condition for online pharmacies and telemedicine providers, and Google's own certification is required of advertisers as well (PAY-237, PAY-240, PAY-241). Check which of these programs, if any, describes your business.

The certification lines are written for online pharmacies and telemedicine providers (PAY-237, PAY-240). In plainer words, the stated accreditation conditions are about those two kinds of business (PAY-237, PAY-240). The sources captured for this guide do not say whether a store selling peptides qualifies as either. Ask a licensed attorney whether these lines apply to your store.

What does Google say about speculative or experimental treatments?

Google does not allow promotion of speculative and/or experimental medical treatments (PAY-224). It also does not allow promotion of cell or gene therapies, subject to the exception for the United States (PAY-225). The exception states that in the United States Google allows the promotion of FDA licensed or approved cell or gene therapies by entities that hold the relevant FDA license or approval to market that product (PAY-226). In plainer words, the exception applies in the United States to licensed or approved therapies promoted by the entities holding that license or approval (PAY-226). Read the exception's full wording in the table below before comparing it with your own pages.

What are the clinical trial recruitment rules?

Google states it doesn't allow the promotion of clinical trial recruitment in most locations (PAY-228). Where promotion is allowed, prescription drugs may not be promoted (PAY-229). Promotions may not create misleading expectations or effects of a product being tested (PAY-230), and may not imply that the products being tested are safe (PAY-231). In plainer words, where the page allows recruitment promotion, prescription drugs may not be promoted and promotions may not imply that the products are safe (PAY-229, PAY-231). Compare any recruitment wording on your own pages against these conditions.

How do the location tables differ?

Google's location table allows online pharmacies in the United Kingdom "if they're registered with the General Pharmaceutical Council (GPhC)", and says "Advertisers must also be certified with Google" (PAY-578). The same row says advertisers can't promote prescription drugs in their ads and landing pages (PAY-578). In Ireland, Google doesn't allow the promotion of online pharmacies that offer prescription collection, delivery services, sale of non-medicinal products, or online consultation (not including consultation with a doctor) (PAY-544). In Poland it doesn't allow the promotion of any online pharmacies (PAY-564). Unlike the United Kingdom row, the Ireland and Poland rows state that Google doesn't allow the promotion of the online pharmacies they describe (PAY-578, PAY-544, PAY-564). Check the row for each country you target.

Under its Prescription drug services lines, Google tells advertisers to check the location-specific restrictions for every location where they plan to advertise (PAY-210). It also says advertisers are expected to familiarize themselves with the local law and regulations for any location their ads target (PAY-235). In plainer words, the advertiser is told to check the restrictions for each targeted location and to learn the local law there (PAY-210, PAY-235). Read the row for each location you target in the page itself.

What about Meta?

Meta's drugs and pharmaceuticals ad standard could not be read on 2026-10-08, so this guide reports nothing from it (PAY-012). The capture returned HTTP 200 but contained a script shell with a load failure marker and no policy text on drugs, prescriptions or unapproved substances (PAY-012). The captured sources do not say what Meta's rules say, and they do not show whether Meta is more or less strict than Google. Read Meta's current standard directly before relying on any comparison with Google.

What do the sources captured for this guide not say?

The captured Google Ads entries do not say that Google allows or disallows any peptide ad, and they do not mention peptides. They do not define which products Google treats as unapproved pharmaceuticals and supplements beyond a non-exhaustive list (PAY-009), and they do not say how a reviewer applies the regulatory action or warning line (PAY-205). They do not include Meta's text (PAY-012). Each gap is a reason to read the original page and to talk to a licensed attorney about a specific situation.

FAQ

Does this article say Google Ads allows peptide ads?

No. The captured Google Ads entries do not mention peptides, and the page says some types of healthcare-related content can't be advertised at all (PAY-233).

What does "regardless of any claims of legality" mean on the page?

That is the page's wording: Google doesn't allow the promotion of certain products, regardless of any claims of legality, for items on a non-exhaustive list (PAY-009).

Does the page mention LegitScript?

Yes. It names LegitScript certification for online pharmacies and for telemedicine providers, and adds that advertisers must also be certified with Google (PAY-237, PAY-240, PAY-241).

What does the page say about products that received a regulatory warning?

It lists products that have been subject to any government or regulatory action or warning (PAY-205).

What happens when the Unauthorized pharmacies policy is violated?

The page states that accounts will be suspended upon detection and without prior warning, and the advertiser will not be allowed to advertise with Google Ads again (PAY-216).

Can an advertiser appeal?

The page states that an advertiser who believes there has been an error can submit an appeal and explain why (PAY-503).

Was Meta's policy checked?

The Meta page could not be read on 2026-10-08, so this guide reports nothing from it (PAY-012).

Is this legal advice?

No. Talk to a licensed attorney for your situation.

Sources

Talk to a licensed attorney for your situation.